Premium
Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group
Author(s) -
Zammarchi Lorenzo,
Bonati Maurizio,
Strohmeyer Marianne,
Albonico Marco,
RequenaMéndez Ana,
Bisoffi Zeno,
Nicoletti Alessandra,
García Hector H.,
Bartoloni Alessandro
Publication year - 2017
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/tmi.12887
Subject(s) - cysticercosis , taeniasis , taenia solium , neurocysticercosis , medicine , taenia , helminthiasis , environmental health , helminths , immunology , cestode infections , pediatrics , pathology
Neurocysticercosis, the central nervous system's localised form of cysticercosis, is considered to be the leading cause of epilepsy in the developing world. In Europe, the disease is mainly imported and affects both immigrants and travellers. However, autochthonous cases of cysticercosis in low‐endemic countries could also originate from Taenia solium carriers (migrants or travellers) who acquired taeniasis overseas. Management of cysticercosis is a challenge for European healthcare providers as they are often hardly aware of this infection and have little familiarity in managing this disease. This study provides a summary of recommendations concerning screening, diagnosis and management of cysticercosis and T. solium taeniasis in Europe drawn up by nine experts in migrant health and imported diseases with experience in cysticercosis and T. solium taeniasis.